Impact of risk factors on early cancer evolution
Cell · 2023
DOI: 10.1016/j.cell.2023.03.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell, 2023. Verfasst von Clare E Weeden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 136-mal zitiert (Crossref) und nennt 267 Literaturangaben. Gefördert von: Cancer Research UK, Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Recent identification of oncogenic cells within healthy tissues and the prevalence of indolent cancers found incidentally at autopsies reveal a greater complexity in tumor initiation than previously appreciated. The human body contains roughly 40 trillion cells of 200 different types that are organized within a complex three-dimensional matrix, necessitating exquisite mechanisms to restrain aberrant outgrowth of malignant cells that have the capacity to kill the host. Understanding how this defense is overcome to trigger tumorigenesis and why cancer is so extraordinarily rare at the cellular level is vital to future prevention therapies. In this review, we discuss how early initiated cells are protected from further tumorigenesis and the non-mutagenic pathways by which cancer risk factors promote tumor growth. By nature, the absence of permanent genomic alterations potentially renders these tumor-promoting mechanisms clinically targetable. Finally, we consider existing strategies for early cancer interception with perspectives on the next steps for molecular cancer prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
- Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Center of Excellence, University College London Cancer Institute, London, UK.
- Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Center of Excellence, University College London Cancer Institute, London, UK; Department of Onc…
Förderung
- Cancer Research UK
- Wellcome Trust
- Medical Research Council
- Rosetrees Trust
- Novo Nordisk Fonden
- Breast Cancer Research Foundation
- Horizon 2020 Framework Programme
- CRUK Lung Cancer Centre of Excellence
Zitieren
APA
Weeden, C. E., Hill, W., Lim, E. L., Grönroos, E., & Swanton, C. (2023). Impact of risk factors on early cancer evolution. Cell. https://doi.org/10.1016/j.cell.2023.03.013
Vancouver
Weeden CE, Hill W, Lim EL, Grönroos E, Swanton C. Impact of risk factors on early cancer evolution. Cell. 2023. doi:10.1016/j.cell.2023.03.013
BibTeX
@article{Weeden2023,
author = {Weeden, Clare E and Hill, William and Lim, Emilia L and Grönroos, Eva and Swanton, Charles},
title = {Impact of risk factors on early cancer evolution},
journal = {Cell},
year = {2023},
doi = {10.1016/j.cell.2023.03.013}
}
EUVIMED